# ECO Animal Health Group receives European positive opinion for Avilosin in pigs

- Link: https://www.directorstalkinterviews.com/eco-animal-health-group-receives-european-positive-opinion-for-avilosin-in-pigs/412825217
- Published: 2020-05-26T15:28:55+01:00
- Author: Giles Arbor

**ECO Animal Health Group plc** (LON:EAH) has announced that its subsidiary ECO 
Animal Health Limited (ECO) has received a positive opinion from the European Medicines
Agency (EMA) for the use of Aivlosin® 625 mg/g Water Soluble Granules (WSG) for 
the treatment and metaphylaxis (disease control) of _Mycoplasma hyopneumoniae_ in
pigs.  

_Mycoplasma hyopneumoniae_ is the most common primary pathogen in pig respiratory
disease and is a key instigator of secondary bacterial and viral pathogens.

Aivlosin®, ECO’s patented antimicrobial, is used under veterinary prescription for
the treatment of a variety of economically important respiratory and enteric (gut)
diseases in poultry and pigs.

The European Commission is expected to issue a marketing authorisation within two
months of the publication of a positive opinion.

> **Marc Loomes, ECO Animal Health Group CEO, commented: **
> “Aivlosin® offers a safe and highly effective medication for Mycoplasma infections.
> This positive opinion is significant, not only in the EU which has fifteen per
> cent of the world’s pigs but for other large international swine markets as this
> indication is rolled out. Whilst we bring forward our new product development 
> programme, particularly around vaccines, it is important to note that Aivlosin
> ® ‘s approved usage continues to expand across multiple treatment areas and markets.”

Share on:
